Report Detail

Request for Sample of this report

Other Global Parkinson Treatment Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4626367
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Parkinson Treatment Drug market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Parkinson Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Parkinson Treatment Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global Parkinson Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Parkinson Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Parkinson Treatment Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parkinson Treatment Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parkinson Treatment Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Parkinson Treatment Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sinemet-CR
Piribedil
Madopar
COMT Inhibitor
Others
Market segment by Application
Male Patient
Female Patient
Market segment by players, this report covers
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Parkinson Treatment Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson Treatment Drug, with revenue, gross margin, and global market share of Parkinson Treatment Drug from 2020 to 2025.
Chapter 3, the Parkinson Treatment Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Parkinson Treatment Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson Treatment Drug.
Chapter 13, to describe Parkinson Treatment Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Parkinson Treatment Drug by Type
    • 1.3.1 Overview: Global Parkinson Treatment Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Parkinson Treatment Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 Sinemet-CR
    • 1.3.4 Piribedil
    • 1.3.5 Madopar
    • 1.3.6 COMT Inhibitor
    • 1.3.7 Others
  • 1.4 Global Parkinson Treatment Drug Market by Application
    • 1.4.1 Overview: Global Parkinson Treatment Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Male Patient
    • 1.4.3 Female Patient
  • 1.5 Global Parkinson Treatment Drug Market Size & Forecast
  • 1.6 Global Parkinson Treatment Drug Market Size and Forecast by Region
    • 1.6.1 Global Parkinson Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Parkinson Treatment Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America Parkinson Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Parkinson Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Parkinson Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America Parkinson Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Parkinson Treatment Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Parkinson Treatment Drug Product and Solutions
    • 2.1.4 Merck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments and Future Plans
  • 2.2 Akorn
    • 2.2.1 Akorn Details
    • 2.2.2 Akorn Major Business
    • 2.2.3 Akorn Parkinson Treatment Drug Product and Solutions
    • 2.2.4 Akorn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Akorn Recent Developments and Future Plans
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Parkinson Treatment Drug Product and Solutions
    • 2.3.4 GSK Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 GSK Recent Developments and Future Plans
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Parkinson Treatment Drug Product and Solutions
    • 2.4.4 Novartis Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Novartis Recent Developments and Future Plans
  • 2.5 Boehringer Ingelheim
    • 2.5.1 Boehringer Ingelheim Details
    • 2.5.2 Boehringer Ingelheim Major Business
    • 2.5.3 Boehringer Ingelheim Parkinson Treatment Drug Product and Solutions
    • 2.5.4 Boehringer Ingelheim Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.6 Teva Pharmaceutical
    • 2.6.1 Teva Pharmaceutical Details
    • 2.6.2 Teva Pharmaceutical Major Business
    • 2.6.3 Teva Pharmaceutical Parkinson Treatment Drug Product and Solutions
    • 2.6.4 Teva Pharmaceutical Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Teva Pharmaceutical Recent Developments and Future Plans
  • 2.7 Abbvie
    • 2.7.1 Abbvie Details
    • 2.7.2 Abbvie Major Business
    • 2.7.3 Abbvie Parkinson Treatment Drug Product and Solutions
    • 2.7.4 Abbvie Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Abbvie Recent Developments and Future Plans
  • 2.8 Kyowa Hakko Kirin Pharma
    • 2.8.1 Kyowa Hakko Kirin Pharma Details
    • 2.8.2 Kyowa Hakko Kirin Pharma Major Business
    • 2.8.3 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product and Solutions
    • 2.8.4 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
  • 2.9 Astellas Pharma
    • 2.9.1 Astellas Pharma Details
    • 2.9.2 Astellas Pharma Major Business
    • 2.9.3 Astellas Pharma Parkinson Treatment Drug Product and Solutions
    • 2.9.4 Astellas Pharma Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Astellas Pharma Recent Developments and Future Plans
  • 2.10 Desitin Arzneimittel
    • 2.10.1 Desitin Arzneimittel Details
    • 2.10.2 Desitin Arzneimittel Major Business
    • 2.10.3 Desitin Arzneimittel Parkinson Treatment Drug Product and Solutions
    • 2.10.4 Desitin Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Desitin Arzneimittel Recent Developments and Future Plans
  • 2.11 Endo Pharmaceuticals
    • 2.11.1 Endo Pharmaceuticals Details
    • 2.11.2 Endo Pharmaceuticals Major Business
    • 2.11.3 Endo Pharmaceuticals Parkinson Treatment Drug Product and Solutions
    • 2.11.4 Endo Pharmaceuticals Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans
  • 2.12 F.Hoffmann-La Roche
    • 2.12.1 F.Hoffmann-La Roche Details
    • 2.12.2 F.Hoffmann-La Roche Major Business
    • 2.12.3 F.Hoffmann-La Roche Parkinson Treatment Drug Product and Solutions
    • 2.12.4 F.Hoffmann-La Roche Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 F.Hoffmann-La Roche Recent Developments and Future Plans
  • 2.13 H.Lundbeck
    • 2.13.1 H.Lundbeck Details
    • 2.13.2 H.Lundbeck Major Business
    • 2.13.3 H.Lundbeck Parkinson Treatment Drug Product and Solutions
    • 2.13.4 H.Lundbeck Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 H.Lundbeck Recent Developments and Future Plans
  • 2.14 Valeant
    • 2.14.1 Valeant Details
    • 2.14.2 Valeant Major Business
    • 2.14.3 Valeant Parkinson Treatment Drug Product and Solutions
    • 2.14.4 Valeant Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Valeant Recent Developments and Future Plans
  • 2.15 Apokyn
    • 2.15.1 Apokyn Details
    • 2.15.2 Apokyn Major Business
    • 2.15.3 Apokyn Parkinson Treatment Drug Product and Solutions
    • 2.15.4 Apokyn Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Apokyn Recent Developments and Future Plans
  • 2.16 Orion
    • 2.16.1 Orion Details
    • 2.16.2 Orion Major Business
    • 2.16.3 Orion Parkinson Treatment Drug Product and Solutions
    • 2.16.4 Orion Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Orion Recent Developments and Future Plans
  • 2.17 Stada Arzneimittel
    • 2.17.1 Stada Arzneimittel Details
    • 2.17.2 Stada Arzneimittel Major Business
    • 2.17.3 Stada Arzneimittel Parkinson Treatment Drug Product and Solutions
    • 2.17.4 Stada Arzneimittel Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Stada Arzneimittel Recent Developments and Future Plans
  • 2.18 US WorldMeds
    • 2.18.1 US WorldMeds Details
    • 2.18.2 US WorldMeds Major Business
    • 2.18.3 US WorldMeds Parkinson Treatment Drug Product and Solutions
    • 2.18.4 US WorldMeds Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 US WorldMeds Recent Developments and Future Plans
  • 2.19 Bausch Health
    • 2.19.1 Bausch Health Details
    • 2.19.2 Bausch Health Major Business
    • 2.19.3 Bausch Health Parkinson Treatment Drug Product and Solutions
    • 2.19.4 Bausch Health Parkinson Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Bausch Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Parkinson Treatment Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Parkinson Treatment Drug by Company Revenue
    • 3.2.2 Top 3 Parkinson Treatment Drug Players Market Share in 2024
    • 3.2.3 Top 6 Parkinson Treatment Drug Players Market Share in 2024
  • 3.3 Parkinson Treatment Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Parkinson Treatment Drug Market: Region Footprint
    • 3.3.2 Parkinson Treatment Drug Market: Company Product Type Footprint
    • 3.3.3 Parkinson Treatment Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Parkinson Treatment Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Parkinson Treatment Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Parkinson Treatment Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Parkinson Treatment Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Parkinson Treatment Drug Consumption Value by Type (2020-2031)
  • 6.2 North America Parkinson Treatment Drug Market Size by Application (2020-2031)
  • 6.3 North America Parkinson Treatment Drug Market Size by Country
    • 6.3.1 North America Parkinson Treatment Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Parkinson Treatment Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Parkinson Treatment Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe Parkinson Treatment Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe Parkinson Treatment Drug Market Size by Country
    • 7.3.1 Europe Parkinson Treatment Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Parkinson Treatment Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Parkinson Treatment Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Parkinson Treatment Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Parkinson Treatment Drug Market Size by Region
    • 8.3.1 Asia-Pacific Parkinson Treatment Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Parkinson Treatment Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Parkinson Treatment Drug Consumption Value by Type (2020-2031)
  • 9.2 South America Parkinson Treatment Drug Consumption Value by Application (2020-2031)
  • 9.3 South America Parkinson Treatment Drug Market Size by Country
    • 9.3.1 South America Parkinson Treatment Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Parkinson Treatment Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Parkinson Treatment Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Parkinson Treatment Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Parkinson Treatment Drug Market Size by Country
    • 10.3.1 Middle East & Africa Parkinson Treatment Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Parkinson Treatment Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Parkinson Treatment Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Parkinson Treatment Drug Market Drivers
  • 11.2 Parkinson Treatment Drug Market Restraints
  • 11.3 Parkinson Treatment Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Parkinson Treatment Drug Industry Chain
  • 12.2 Parkinson Treatment Drug Upstream Analysis
  • 12.3 Parkinson Treatment Drug Midstream Analysis
  • 12.4 Parkinson Treatment Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Parkinson Treatment Drug. Industry analysis & Market Report on Parkinson Treatment Drug is a syndicated market report, published as Global Parkinson Treatment Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Parkinson Treatment Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo